FI923747A0 - Kompositioner och foerfaranden foer behandling av infektioner foerorsakade av organismer sensitiva foer b-laktamantibiotika. - Google Patents

Kompositioner och foerfaranden foer behandling av infektioner foerorsakade av organismer sensitiva foer b-laktamantibiotika.

Info

Publication number
FI923747A0
FI923747A0 FI923747A FI923747A FI923747A0 FI 923747 A0 FI923747 A0 FI 923747A0 FI 923747 A FI923747 A FI 923747A FI 923747 A FI923747 A FI 923747A FI 923747 A0 FI923747 A0 FI 923747A0
Authority
FI
Finland
Prior art keywords
foer
organismer
lactamantibiotics
infektioner
foerorsakade
Prior art date
Application number
FI923747A
Other languages
English (en)
Finnish (fi)
Other versions
FI923747A (fi
Inventor
Richard P Darveau
James J Blake
Wesley L Cosand
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI923747A publication Critical patent/FI923747A/fi
Publication of FI923747A0 publication Critical patent/FI923747A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
FI923747A 1990-02-23 1992-08-20 Kompositioner och foerfaranden foer behandling av infektioner foerorsakade av organismer sensitiva foer b-laktamantibiotika. FI923747A0 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US48402090A 1990-02-23 1990-02-23
US65532191A 1991-02-19 1991-02-19
PCT/US1991/001224 WO1991012815A1 (fr) 1990-02-23 1991-02-25 COMPOSITIONS ET PROCEDES POUR TRAITER DES INFECTIONS CAUSEES PAR DES ORGANISMES SENSIBLES AUX ANTIBIOTIQUES β-LACTAME
OA59988A OA10059A (en) 1990-02-23 1991-04-12 Compositions and methods for treating infections caused by organisms sensitive to beta-lactam antibiotics

Publications (2)

Publication Number Publication Date
FI923747A FI923747A (fi) 1992-08-20
FI923747A0 true FI923747A0 (fi) 1992-08-20

Family

ID=33314051

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923747A FI923747A0 (fi) 1990-02-23 1992-08-20 Kompositioner och foerfaranden foer behandling av infektioner foerorsakade av organismer sensitiva foer b-laktamantibiotika.

Country Status (14)

Country Link
US (1) US5409898A (fr)
EP (1) EP0516747A4 (fr)
JP (1) JPH05506645A (fr)
CN (1) CN1054900A (fr)
AU (1) AU650262B2 (fr)
CA (1) CA2076529A1 (fr)
CZ (1) CZ47791A3 (fr)
FI (1) FI923747A0 (fr)
HU (1) HUT63567A (fr)
IE (1) IE910630A1 (fr)
IL (1) IL97344A (fr)
NZ (1) NZ237202A (fr)
OA (1) OA10059A (fr)
WO (1) WO1991012815A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613734B2 (en) * 1988-01-06 2003-09-02 The Scripps Research Institute Peptides-containing liposomal surfactants
US5885965A (en) * 1991-11-01 1999-03-23 Periodontix, Inc. Anti-fungal D-amino acid histatin-based peptides
US5646119A (en) * 1991-11-01 1997-07-08 Periodontix, Inc. D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
WO1996035804A1 (fr) * 1995-05-08 1996-11-14 Merck & Co., Inc. Nouvelle interaction biochimique dans des bacteries
US5747453A (en) * 1995-06-06 1998-05-05 Alza Corporation Method for increasing the electrotransport flux of polypeptides
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
US6180604B1 (en) 1996-08-21 2001-01-30 Micrologix Biotech Inc. Compositions and methods for treating infections using analogues of indolicidin
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
NL1008139C2 (nl) * 1998-01-27 1999-07-28 Stichting Tech Wetenschapp Antimicrobiële peptiden.
WO1999042119A1 (fr) 1998-02-18 1999-08-26 Harbor-Ucla Research And Education Institute Peptides antimicrobiens et metapeptides derives
US7820619B1 (en) 1998-02-18 2010-10-26 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Antimicrobial peptides and derived metapeptides
US6191168B1 (en) 1998-06-02 2001-02-20 Edward Rubenstein Methods for the use of nonprotein amino acids as therapeutic agents
US6835536B2 (en) 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
CA2457885A1 (fr) 2001-08-24 2003-03-06 Micrologix Biotech Inc. Peptides antimicrobiens et anti-inflammatoires
AR039475A1 (es) 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
EP1534752B1 (fr) 2002-05-01 2011-08-03 Human Genome Sciences, Inc. Anticorps a liaison specifique avec la chimiokine beta-4
AR039774A1 (es) 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
PE20070403A1 (es) * 2005-07-27 2007-05-15 Wyeth Corp COMPOSICION FARMACEUTICA QUE COMPRENDE CEFEPIME Y DERIVADOS DE 6-ALQUILIDEN-PENEM BICICLICOS COMO INHIBIDORES DE ß-LACTAMASA
EP2536408A1 (fr) * 2010-02-16 2012-12-26 Wockhardt Research Centre Inhibiteurs de pompe à écoulement
EA029419B1 (ru) 2010-11-19 2018-03-30 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Нейтрализующие антитела против ccl20
WO2012068187A1 (fr) * 2010-11-19 2012-05-24 Merck Sharp & Dohme Corp. Polymères poly(amide) destinés à l'administration d'oligonucléotides
CN107320727A (zh) * 2016-04-29 2017-11-07 四川大学 抗菌肽与抗生素组合抗菌药物及其使用方法
US20230414719A1 (en) * 2020-11-09 2023-12-28 Arizona Board Of Regents On Behalf Of Arizona State University Methods of using platelet factor 4 as an antimicrobial agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE436645C (sv) * 1976-04-29 1996-07-22 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4543252A (en) * 1982-01-21 1985-09-24 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US4659692A (en) * 1982-11-19 1987-04-21 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US4810777A (en) * 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
US5045531A (en) * 1989-12-18 1991-09-03 Magainin Sciences Inc. Wound treatment employing biologically active ion channel forming peptides and proteins

Also Published As

Publication number Publication date
OA10059A (en) 1996-10-14
CN1054900A (zh) 1991-10-02
AU650262B2 (en) 1994-06-16
EP0516747A1 (fr) 1992-12-09
FI923747A (fi) 1992-08-20
IE910630A1 (en) 1991-08-28
WO1991012815A1 (fr) 1991-09-05
AU7485691A (en) 1991-09-18
JPH05506645A (ja) 1993-09-30
CA2076529A1 (fr) 1991-08-24
NZ237202A (en) 1994-01-26
US5409898A (en) 1995-04-25
IL97344A0 (en) 1992-05-25
HUT63567A (en) 1993-09-28
HU9202720D0 (en) 1992-12-28
CZ47791A3 (en) 1993-04-14
IL97344A (en) 1995-12-31
EP0516747A4 (en) 1993-03-24

Similar Documents

Publication Publication Date Title
FI923747A0 (fi) Kompositioner och foerfaranden foer behandling av infektioner foerorsakade av organismer sensitiva foer b-laktamantibiotika.
FI912075A0 (fi) Haorbehandlingskomposition i form av en mikroemulsion och foerfarande foer framstaellning och anvaendning av densamma.
FI906444A (fi) Paofyllbar polyesterkaerl och foer form foer bildande av detta.
FI900409A0 (fi) Saett och anordning foer inmatning av reaktionsaemnen i en smaeltugn.
FI900031A (fi) Foerfarande och anordning foer behandling av gaser fraon foergasnings- eller foerbraenningsanlaeggningar.
FI905399A (fi) Foerfarande och anordning foer framkallning av kantspaenning i vindruta i boejningsugn foer vindrutor.
FI912160A0 (fi) Komposition foer behandling av osteoporos och hormonell obalans.
FI911644A0 (fi) Terapeutisk foerening och komposition.
FI910012A (fi) Styrfoerfarande och styrsats foer daempning av resonanssvaengningar i en parallellsvaengkrets foer en pulsvaexelriktare i en stroemmellankretsomformare.
FI931963A0 (fi) Foerfarande och anordning foer avlaegsning av blaeck fraon avfallspappersmaterial
FI906118A0 (fi) Foerfarande och form foer gjutning av plattbelaeggning.
FI900168A0 (fi) Foerfarande och anordning foer borning av kanaloeppning.
FI902001A0 (fi) Anordning foer istaondsaettning av spetslisten i inloppslaodan av en pappermaskin och istaondsaettningsfoerfarande.
FI904541A0 (fi) Belaeggningstav foer stavbelaeggningsanordning och foerfarande foer framstaellning av denna.
FI905527A (fi) Foerfarande och anordning foer oljeservice och foer separering av vatten fraon oljan i oljecirkulationskretsen.
FI922769A (fi) Foerfarande och anordning foer riktning av utboejningar i hissgejder.
FI905578A (fi) Foerfarande foer fogning av en vaermeisoleringsskiva och en i foerfarandet anvaend vaermeisoleringsskiva.
FI906337A0 (fi) Foerfarande och anordning foer reglering av laeppkonan i inloppslaodan av en pappersmaskin.
FI905048A0 (fi) Foerfarande och anordning foer separering av vatten fraon olja i en oljecirkulationskrets.
FI904976A0 (fi) Foerfarande och anordning foer reglering av foerbraenningsluftstroem i vaermealstringsanordning.
FI904882A (fi) Anordning foer foervaring av groensaker och i synnerhet rotsaker.
FI901566A0 (fi) Foerfarande foer framstaellning av en kabelfoerbindning i en anslutningsdos och anslutningsdosan.
FI902894A0 (fi) Foerfarande och anordning foer avlaegsnande av icke oenskade komponenter fraon vattenhaltiga inmatningsmaterial.
FI900001A0 (fi) Foerfarande och anordning foer behandling av betongyta.
FI900020A0 (fi) Foerfarande och anordning foer visualisering av ultraljudsbild.

Legal Events

Date Code Title Description
FD Application lapsed